UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (192) 192
life sciences & biomedicine (158) 158
neurosciences & neurology (134) 134
humans (133) 133
alzheimer's disease (128) 128
male (111) 111
female (110) 110
neurosciences (101) 101
clinical neurology (96) 96
aged (87) 87
neurology (78) 78
middle aged (68) 68
magnetic resonance imaging (57) 57
dementia (56) 56
neuroimaging (54) 54
aged, 80 and over (46) 46
cognitive ability (42) 42
alzheimer disease - genetics (39) 39
biomarkers (37) 37
adult (36) 36
neurodegenerative diseases (35) 35
multidisciplinary sciences (33) 33
science & technology - other topics (33) 33
alzheimer disease - diagnostic imaging (32) 32
brain (32) 32
alzheimers disease (31) 31
medical imaging (31) 31
alzheimer’s disease (30) 30
neuropsychological tests (30) 30
abridged index medicus (29) 29
psychiatry (28) 28
brain - diagnostic imaging (24) 24
dementia disorders (24) 24
memory (24) 24
alzheimer disease - diagnosis (22) 22
alzheimer disease - pathology (22) 22
geriatrics & gerontology (22) 22
positron emission tomography (21) 21
positron-emission tomography (21) 21
alzheimer disease - metabolism (20) 20
alzheimer disease - physiopathology (20) 20
brain - pathology (20) 20
cognition (20) 20
disease progression (20) 20
longitudinal studies (19) 19
medical research (19) 19
medicine, experimental (19) 19
risk factors (19) 19
aging (18) 18
mental disorders (18) 18
cerebrospinal fluid (17) 17
clinical trials (17) 17
diagnosis (17) 17
medicine (17) 17
nuclear magnetic resonance--nmr (17) 17
science (17) 17
severity of illness index (17) 17
alzheimer disease - cerebrospinal fluid (16) 16
alzheimer disease - psychology (16) 16
brain - metabolism (16) 16
genetics (16) 16
genetic aspects (15) 15
medical colleges (15) 15
neuroscience (15) 15
research (15) 15
alzheimer disease - drug therapy (14) 14
amyloid (14) 14
amyloid beta-peptides - metabolism (14) 14
atrophy (14) 14
mutation (14) 14
alzheimer disease (13) 13
amyloid beta-peptides - cerebrospinal fluid (13) 13
double-blind method (13) 13
tau protein (13) 13
tau proteins - cerebrospinal fluid (13) 13
apolipoprotein e (12) 12
apolipoproteins e - genetics (12) 12
cohort studies (12) 12
mild cognitive impairment (12) 12
original (12) 12
pathology (12) 12
regression analysis (12) 12
social sciences (12) 12
treatment outcome (12) 12
algorithms (11) 11
alzheimer disease - complications (11) 11
biomarkers - cerebrospinal fluid (11) 11
brain research (11) 11
cognition disorders - diagnosis (11) 11
heterozygote (11) 11
patients (11) 11
psychology (11) 11
tau (11) 11
cognitive dysfunction - diagnostic imaging (10) 10
neural networks (10) 10
neurovetenskaper (10) 10
original articles (10) 10
cortex (9) 9
cross-sectional studies (9) 9
data processing (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 01/2014, Volume 370, Issue 4, pp. 322 - 333
In two phase 3 trials in patients with Alzheimer's disease, bapineuzumab, a humanized anti–amyloid-beta monoclonal antibody, did not improve clinical outcomes.... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Phosphorylation | Humans | Middle Aged | Male | Positron-Emission Tomography | Treatment Failure | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Biomarkers - analysis | Alzheimer Disease - drug therapy | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Cognition - drug effects | Neuropsychological Tests | Amyloid beta-Peptides - antagonists & inhibitors | Apolipoproteins E - genetics | Intention to Treat Analysis | Amyloid beta-Peptides - analysis | Brain - pathology | Aged | Biomarkers - cerebrospinal fluid | Edema - chemically induced | Alzheimer Disease - genetics | Monoclonal antibodies | Product development | Research | Drug therapy | Alzheimer's disease | Health aspects | Edema | Nuclear magnetic resonance--NMR | Intravenous administration | Neurodegenerative diseases | Cognitive ability | Clinical trials | Cerebrospinal fluid | Patients | Studies | Tau protein | Apolipoprotein E | Immunotherapy | Alleles | Dementia disorders | Alzheimers disease | Index Medicus | Abridged Index Medicus | Brain | Neurosciences | pathology | Biological Markers | Antibodies | Cognition | tau Proteins | 80 and over | genetics | Amyloid beta-Peptides | Apolipoproteins E | Monoclonal | Neurovetenskaper | drug therapy | chemically induced | Humanized | drug effects | Alzheimer Disease | analysis | antagonists & inhibitors | cerebrospinal fluid | adverse effects | therapeutic use
Journal Article
Nature communications, ISSN 2041-1723, 06/2016, Volume 7, Issue 1, pp. 11934 - 11934
Journal Article
Journal Article
Journal Article
Journal of Alzheimer's disease, ISSN 1387-2877, 2018, Volume 64, Issue 3, pp. 689 - 707
Journal Article